PRICE T ROWE ASSOCIATES INC /MD/
Position in GPCR — Structure Therapeutics Inc.
CIK 80255
BALTIMORE, MD
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$96,433,547
-$19,794,100 QoQ
Shares Held
2,000,696
+19.7% QoQ
Ownership
0.938%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. GPCR ranks #32 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in GPCR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96,433,547 | 2,000,696 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $116,227,647 | 1,671,138 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,103,004 | 289,393 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,318,482 | 352,868 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,452,864 | 777,173 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $37,813,578 | 1,394,306 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $91,496,912 | 2,084,687 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $90,851,969 | 2,313,521 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $66,902,317 | 1,560,950 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $68,453,811 | 1,679,436 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $126,733,846 | 2,513,563 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $73,718,159 | 1,773,350 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,710,953 | 786,505 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||